Vaccine Efficacy
- All
- News
- Videos
-
Serum Institute's New "High Efficacy" Malaria Vaccine Rolls Out In Africa
- Monday July 15, 2024
- World News | Press Trust of India
A new "high efficacy" malaria vaccine co-developed by the Serum Institute of India (SII) and the University of Oxford was officially rolled out on Monday when Cote d'Ivoire in West Africa became the first country to begin administering R21/Matrix-M.
- www.ndtv.com
-
Oxford University, Serum Institute Deliver 'High Efficacy' Malaria Vaccine
- Thursday April 13, 2023
- India News | Press Trust of India
A University of Oxford developed and Serum Institute of India (SII) manufactured and scaled up "high efficacy" malaria vaccine has been licensed for use in Ghana by Africa's Food and Drugs Authority, the university announced here on Thursday.
- www.ndtv.com
-
World Sleep Day 2023: Lack Of Proper Sleep Can Affect The Efficacy Of Vaccinations
- Friday March 17, 2023
- Manya Singh
Let's discuss why we recognise World Sleep Day and the link between good quality sleep and how that influences the efficacy of vaccinations.
- doctor.ndtv.com
-
Pfizer Chief Ignores Questions About Covid Vaccine's Efficacy In Davos: Report
- Friday January 20, 2023
- World News | Asian News International
Albert Bourla, Chief Executive Officer of US-based pharmaceutical giant Pfizer, encountered a series of tough questions about the efficacy of its Covid vaccine on the sidelines of the ongoing World Economic Forum, but he repeatedly ignored them.
- www.ndtv.com
-
Sudden Covid Outbreaks Show "Lack Of Efficacy" Of Chinese Vaccines: Report
- Tuesday December 27, 2022
- World News | Asian News International
China's sudden COVID-19 outbreaks "demonstrate a lack of effectiveness of its vaccines", prompting global concerns, particularly in nations where Beijing's vaccines have been accepted, Tibet Press reported.
- www.ndtv.com
-
Bharat Biotech To Launch 1st Nasal Covid Vaccine, No Efficacy Data Released
- Monday November 28, 2022
- India News | NDTV News Desk
Bharat Biotech's needle-free intranasal Covid vaccine has been cleared for restricted use in emergency situations for those above the age of 18 years. iNCOVACC will become the first intranasal vaccine in the world.
- www.ndtv.com
-
Covid Vaccination Improves Efficacy Of Cancer Treatment, Says Study
- Friday November 11, 2022
- World News | Edited by Nikhil Pandey
Researchers were concerned that Covid vaccine would reduce the effectiveness of drugs used to treat nasopharyngeal cancer, a type of throat cancer, but a new study shows the opposite.
- www.ndtv.com
-
Covaxin Booster Enhances Efficacy Against Delta, Omicron Variants: Study
- Wednesday June 15, 2022
- India News | Press Trust of India
The administration of Covaxin as a booster dose enhances vaccine effectiveness against COVID-19's Delta variant and gives protection against Omicron variants BA.1.1 and BA.2, a study by ICMR and Bharat Biotech has found.
- www.ndtv.com
-
US Health Authority Says Moderna Covid Vaccine Effective In Under-Fives
- Saturday June 11, 2022
- World News | Agence France-Presse
US health authorities confirmed on Friday that data provided by drug-maker Moderna on the efficacy of its Covid-19 vaccine among very young children were accurate.
- www.ndtv.com
-
No Doubts On Safety, Efficacy: WHO Chief Scientist On Covaxin Suspension
- Thursday April 21, 2022
- India News | Reported by Ankita Mukherji, Edited by Anindita Sanyal
Soumya Swaminathan, Chief Scientist at the World Health Organisation, today assured that the freeze on Bharat Biotech's Covaxin supply does not involve the safety or efficacy of the vaccine, but some issues in manufacturing processes for which correc
- www.ndtv.com
-
WHO Suspends UN Supply Of Covaxin; No Impact On Efficacy, Says Bharat Biotech
- Sunday April 3, 2022
- India News | Reported by Vishnu Som, Edited by Debanish Achom
The World Health Organisation said on Saturday it has suspended supply through United Nations agencies of COVID-19 vaccine Covaxin, produced by India's Bharat Biotech, to allow the manufacturer to upgrade facilities.
- www.ndtv.com
-
Covishield Dose Gap Reduced To 8-16 Weeks From 12-16
- Sunday March 20, 2022
- India News | Press Trust of India
India's apex body on immunisation NTAGI has recommended administering the second dose of COVID-19 vaccine Covishield between eight and 16 weeks after the first dose.
- www.ndtv.com
-
Covid Booster Efficacy Reduces Significantly By 4th Month: US Study
- Monday February 14, 2022
- World News | Agence France-Presse
The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
- www.ndtv.com
-
How Long Does A Covid Booster Shot Offer Protection? US Study Answers
- Saturday February 12, 2022
- World News | Agence France-Presse
The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
- www.ndtv.com
-
Covishield, Covaxin To Be Available In Hospitals, Clinics In New Approval
- Thursday January 27, 2022
- India News | Reported by Parimal Kumar, Edited by Debanish Achom
Covishield and Covaxin have been cleared by India's drugs regulator for sale in the market, sources have said.
- www.ndtv.com
-
Serum Institute's New "High Efficacy" Malaria Vaccine Rolls Out In Africa
- Monday July 15, 2024
- World News | Press Trust of India
A new "high efficacy" malaria vaccine co-developed by the Serum Institute of India (SII) and the University of Oxford was officially rolled out on Monday when Cote d'Ivoire in West Africa became the first country to begin administering R21/Matrix-M.
- www.ndtv.com
-
Oxford University, Serum Institute Deliver 'High Efficacy' Malaria Vaccine
- Thursday April 13, 2023
- India News | Press Trust of India
A University of Oxford developed and Serum Institute of India (SII) manufactured and scaled up "high efficacy" malaria vaccine has been licensed for use in Ghana by Africa's Food and Drugs Authority, the university announced here on Thursday.
- www.ndtv.com
-
World Sleep Day 2023: Lack Of Proper Sleep Can Affect The Efficacy Of Vaccinations
- Friday March 17, 2023
- Manya Singh
Let's discuss why we recognise World Sleep Day and the link between good quality sleep and how that influences the efficacy of vaccinations.
- doctor.ndtv.com
-
Pfizer Chief Ignores Questions About Covid Vaccine's Efficacy In Davos: Report
- Friday January 20, 2023
- World News | Asian News International
Albert Bourla, Chief Executive Officer of US-based pharmaceutical giant Pfizer, encountered a series of tough questions about the efficacy of its Covid vaccine on the sidelines of the ongoing World Economic Forum, but he repeatedly ignored them.
- www.ndtv.com
-
Sudden Covid Outbreaks Show "Lack Of Efficacy" Of Chinese Vaccines: Report
- Tuesday December 27, 2022
- World News | Asian News International
China's sudden COVID-19 outbreaks "demonstrate a lack of effectiveness of its vaccines", prompting global concerns, particularly in nations where Beijing's vaccines have been accepted, Tibet Press reported.
- www.ndtv.com
-
Bharat Biotech To Launch 1st Nasal Covid Vaccine, No Efficacy Data Released
- Monday November 28, 2022
- India News | NDTV News Desk
Bharat Biotech's needle-free intranasal Covid vaccine has been cleared for restricted use in emergency situations for those above the age of 18 years. iNCOVACC will become the first intranasal vaccine in the world.
- www.ndtv.com
-
Covid Vaccination Improves Efficacy Of Cancer Treatment, Says Study
- Friday November 11, 2022
- World News | Edited by Nikhil Pandey
Researchers were concerned that Covid vaccine would reduce the effectiveness of drugs used to treat nasopharyngeal cancer, a type of throat cancer, but a new study shows the opposite.
- www.ndtv.com
-
Covaxin Booster Enhances Efficacy Against Delta, Omicron Variants: Study
- Wednesday June 15, 2022
- India News | Press Trust of India
The administration of Covaxin as a booster dose enhances vaccine effectiveness against COVID-19's Delta variant and gives protection against Omicron variants BA.1.1 and BA.2, a study by ICMR and Bharat Biotech has found.
- www.ndtv.com
-
US Health Authority Says Moderna Covid Vaccine Effective In Under-Fives
- Saturday June 11, 2022
- World News | Agence France-Presse
US health authorities confirmed on Friday that data provided by drug-maker Moderna on the efficacy of its Covid-19 vaccine among very young children were accurate.
- www.ndtv.com
-
No Doubts On Safety, Efficacy: WHO Chief Scientist On Covaxin Suspension
- Thursday April 21, 2022
- India News | Reported by Ankita Mukherji, Edited by Anindita Sanyal
Soumya Swaminathan, Chief Scientist at the World Health Organisation, today assured that the freeze on Bharat Biotech's Covaxin supply does not involve the safety or efficacy of the vaccine, but some issues in manufacturing processes for which correc
- www.ndtv.com
-
WHO Suspends UN Supply Of Covaxin; No Impact On Efficacy, Says Bharat Biotech
- Sunday April 3, 2022
- India News | Reported by Vishnu Som, Edited by Debanish Achom
The World Health Organisation said on Saturday it has suspended supply through United Nations agencies of COVID-19 vaccine Covaxin, produced by India's Bharat Biotech, to allow the manufacturer to upgrade facilities.
- www.ndtv.com
-
Covishield Dose Gap Reduced To 8-16 Weeks From 12-16
- Sunday March 20, 2022
- India News | Press Trust of India
India's apex body on immunisation NTAGI has recommended administering the second dose of COVID-19 vaccine Covishield between eight and 16 weeks after the first dose.
- www.ndtv.com
-
Covid Booster Efficacy Reduces Significantly By 4th Month: US Study
- Monday February 14, 2022
- World News | Agence France-Presse
The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
- www.ndtv.com
-
How Long Does A Covid Booster Shot Offer Protection? US Study Answers
- Saturday February 12, 2022
- World News | Agence France-Presse
The efficacy of third doses of the Pfizer and Moderna mRNA vaccines wanes substantially by the fourth month after administration, a new study by the US Centers of Disease Control and Prevention (CDC) said Friday.
- www.ndtv.com
-
Covishield, Covaxin To Be Available In Hospitals, Clinics In New Approval
- Thursday January 27, 2022
- India News | Reported by Parimal Kumar, Edited by Debanish Achom
Covishield and Covaxin have been cleared by India's drugs regulator for sale in the market, sources have said.
- www.ndtv.com